DeepRad.AI INC.
Update：2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
DeepLung-CAC
The product is an all-in-one screening system targeting the chest region, encompassing the lung, heart, and bone. Utilizing deep learning analysis on low-dose chest CT scans, this multi-module system is capable of automatically detecting lun
The product is an all-in-one screening system targeting the chest region, encompassing the lung, heart, and bone. Utilizing deep learning analysis on low-dose chest CT scans, this multi-module system is capable of automatically detecting lun
The content above was translated by Ai
Founded Year
2023
Unified Business No.
94243590
Status
Active
Number of Employees
0
Total Paid-in
Capital
69,071,432 (NT$)
Location of Company
Taiwan
, Taipei City
Overseas Development
Japan
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
AI imaging solutions for preventive medicine, targeting lung cancer, CAD, dementia—asymptomatic diseases crippling society. By capturing early-stage micro-anomalies traditionally overlooked, we go beyond productivity to enable quantifiable, population-wide opportunistic screening, driving real ESG.
The content above was translated by Ai
